These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 13648909)

  • 1. [Electrophoretic investigations on protein fractions of the blood serum in schizophrenic patients and effect of neuroleptic therapy on their dynamics].
    LANDO LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1959; 59(2):135-42. PubMed ID: 13648909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aminazine infiltrates and their effect on the hemogram and serum protein fractions in patients with schizophrenia].
    Safonov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(3):431-5. PubMed ID: 5592754
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrophoretic analysis of blood proteins during largactil therapy of schizophrenic patients].
    GREMBOWICZ Z; LEJA Z
    Pol Tyg Lek (Wars); 1959 Feb; 14(7):300-2. PubMed ID: 13667563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Duration of clinical treatment & its success in schizophrenic psychoses; comparison of neuroleptic therapy with older treatment procedures].
    GADE EB; HEINRICH K
    Nervenarzt; 1958 Aug; 29(8):363-4. PubMed ID: 13578046
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of chlorpromazine upon psychomotor and psychiatric behavior of chronic schizophrenic patients.
    HEILIZER F
    J Nerv Ment Dis; 1959 Apr; 128(4):358-64. PubMed ID: 13665358
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of schizophrenic syndromes with chlorpromazine.
    LAFON R; DUC N; RIBSTEIN M; PAGES H
    Montp Med; 1954 Nov; 46(5):284-91. PubMed ID: 14370104
    [No Abstract]   [Full Text] [Related]  

  • 7. Termination of chlorpromazine with schizophrenic patients.
    GOOD WW; STERLING M; HOLTZMAN WH
    Am J Psychiatry; 1958 Nov; 115(5):443-8. PubMed ID: 13583246
    [No Abstract]   [Full Text] [Related]  

  • 8. Schizophrenic reaction.
    King PD
    Med Trial Tech Q; 1967 Dec; 14(2):51-9. PubMed ID: 6083041
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chlorpromazine in manic-depressive and schizophrenic psychoses].
    EVRARD A; VANDIERENDONCK R
    Belg Tijdschr Geneesk; 1955 Apr; 11(8):401-9. PubMed ID: 14378114
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the effect of RP 4560 alone and with barbiturates in cases of schizophrenic psychoses].
    FERRIO L
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jan; 81(1):196-207. PubMed ID: 13421572
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver function and blood proteins during chlorpromazine therapy of schizophrenia].
    KEUP W
    Monatsschr Psychiatr Neurol; 1955 May; 129(6):476-87. PubMed ID: 14394028
    [No Abstract]   [Full Text] [Related]  

  • 12. [Catamnestic studies at a psychoneurological clinic of schizophrenic patients treated by aminazine].
    KANEVSKAIA FO; TARASOV GK; TSUTSUL'KOVSKAIA MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1958; 58(5):616-24. PubMed ID: 13605200
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of medical treatment on the antithymic activity of schizophrenic patients' serum].
    Domashneva IV; Minsker EI; Panteleeva GP; Tsirkin SIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1199-1203. PubMed ID: 6976054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On various combined methods of treatment of schizophrenic patients resistant to aminazine].
    Baronov VF; Kogan RD; Khrekov PA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):135-8. PubMed ID: 5612995
    [No Abstract]   [Full Text] [Related]  

  • 15. Chlorpromazine in schizophrenic withdrawal and in the withdrawn schizophrenic.
    HINE FR
    J Nerv Ment Dis; 1958 Sep; 127(3):220-7. PubMed ID: 13588376
    [No Abstract]   [Full Text] [Related]  

  • 16. [Permeability of the blood cerebrospinal barrier and its changes following aminazine therapy of schizophrenia].
    ROMEL' TE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1959; 59(2):151-5. PubMed ID: 13648911
    [No Abstract]   [Full Text] [Related]  

  • 17. Weight changes in relation to the characteristics of patients on chlorpromazine.
    PLANANSKY K; HEILIZER F
    J Clin Exp Psychopathol; 1959; 20(1):53-7. PubMed ID: 13641392
    [No Abstract]   [Full Text] [Related]  

  • 18. [Schizophrenia developing over a 27-year period reaching a terminal stage with improvement following chlorpromazine therapy].
    TRILLOT J; BERNARDY J; MARMILLON F
    Ann Med Psychol (Paris); 1957 Dec; 115(5):939-40. PubMed ID: 13498482
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peculiarities of the electrical activity of the brain in schizophrenic patients following the pursuit of therapeutic gymnastics].
    Polesia GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(6):928-32. PubMed ID: 6000194
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlorpromazine in the treatment of the chronic disturbed schizophrenic patient.
    MITCHELL PH
    J Ment Sci; 1956 Jan; 102(426):151-4. PubMed ID: 13307194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.